DsbA catalyzes disulfide bond formation in secreted and outer membrane proteins in bacteria. In pathogens, DsbA is a major facilitator of virulence constituting a target for antivirulence antimicrobial development. However, many pathogens encode multiple and diverse DsbA enzymes for virulence factor folding during infection. The aim of this study was to determine whether our recently identified inhibitors of Escherichia coli K-12 DsbA can inhibit the diverse DsbA enzymes found in two important human pathogens and attenuate their virulence.
Results:
DsbA inhibitors from two chemical classes (phenylthiophene and phenoxyphenyl derivatives) inhibited the virulence of uropathogenic E. coli and Salmonella enterica serovar Typhimurium, encoding two and three diverse DsbA homologues, respectively. Inhibitors blocked the virulence of dsbA null mutants complemented with structurally diverse DsbL and SrgA, suggesting that they were not selective for prototypical DsbA. Structural characterization of DsbA-inhibitor complexes showed that compounds from each class bind in a similar region of the hydrophobic groove adjacent to the Cys30-Pro31-His32-Cys33 (CPHC) active site. Modeling of DsbL- and SrgA-inhibitor interactions showed that these accessory enzymes could accommodate the inhibitors in their different hydrophobic grooves, supporting our in vivo findings. Further, we identified highly conserved residues surrounding the active site for 20 diverse bacterial DsbA enzymes, which could be exploited in developing inhibitors with a broad spectrum of activity.
Innovation and Conclusion:
We have developed tools to analyze the specificity of DsbA inhibitors in bacterial pathogens encoding multiple DsbA enzymes. This work demonstrates that DsbA inhibitors can be developed to target diverse homologues found in bacteria. Antioxid. Redox Signal. 29, 653–666.
Get full access to this article
View all access options for this article.
References
1.
World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/
2.
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL www.R-project.org, 2016. (accessed April4, 2017).
3.
World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. 2017. http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
4.
AdamsLA, SharmaP, MohantyB, IlyichovaOV, MulcairMD, WilliamsML, GleesonEC, TotsikaM, DoakBC, CariaS, RimmerK, HorneJ, ShouldiceSR, VaziraniM, HeadeySJ, PlumbBR, MartinJL, HerasB, SimpsonJS, and ScanlonMJ. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA. Angew Chem Int Ed Engl, 54: 2179–2184, 2015.
5.
AfoninePV, Grosse-KunstleveRW, EcholsN, HeaddJJ, MoriartyNW, MustyakimovM, TerwilligerTC, UrzhumtsevA, ZwartPH, and AdamsPD. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr, 68: 352–367, 2012.
6.
ArmougomF, MorettiS, PoirotO, AudicS, DumasP, SchaeliB, KeduasV, and NotredameC. Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee. Nucleic Acids Res, 34: W604–W608, 2006.
7.
ArtsIS, BallG, LeverrierP, GarvisS, NicolaesV, VertommenD, IzeB, Tamu DufeV, MessensJ, VoulhouxR, and ColletJF. Dissecting the machinery that introduces disulfide bonds in Pseudomonas aeruginosa. MBio, 4: e00912–e00913, 2013.
8.
BlattnerFR, PlunkettGIII, BlochCA, PernaNT, BurlandV, RileyM, Collado-VidesJ, GlasnerJD, RodeCK, MayhewGF, GregorJ, DavisNW, KirkpatrickHA, GoedenMA, RoseDJ, MauB, and ShaoY. The complete genome sequence of Escherichia coli K-12. Science, 277: 1453–1462, 1997.
9.
BouwmanCW, KohliM, KilloranA, TouchieGA, KadnerRJ, and MartinNL. Characterization of SrgA, a Salmonella enterica serovar Typhimurium virulence plasmid-encoded paralogue of the disulfide oxidoreductase DsbA, essential for biogenesis of plasmid-encoded fimbriae. J Bacteriol, 185: 991–1000, 2003.
10.
BrannonJR and HadjifrangiskouM. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Drug Des Devel Ther, 10: 1795–1806, 2016.
11.
CegelskiL, MarshallGR, EldridgeGR, and HultgrenSJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol, 6: 17–27, 2008.
12.
ChangJM, Di TommasoP, LefortV, GascuelO, and NotredameC. TCS: a web server for multiple sequence alignment evaluation and phylogenetic reconstruction. Nucleic Acids Res, 43: W3–W6, 2015.
13.
ChangJM, Di TommasoP, and NotredameC. TCS: a new multiple sequence alignment reliability measure to estimate alignment accuracy and improve phylogenetic tree reconstruction. Mol Biol Evol, 31: 1625–1637, 2014.
14.
ChangJM, Di TommasoP, TalyJF, and NotredameC. Accurate multiple sequence alignment of transmembrane proteins with PSI-Coffee. BMC Bioinformatics, 13Suppl 4: S1, 2012.
15.
ChimN, HarmstonCA, GuzmanDJ, and GouldingCW. Structural and biochemical characterization of the essential DsbA-like disulfide bond forming protein from Mycobacterium tuberculosis. BMC Struct Biol, 13: 23, 2013.
16.
CrowA, LewinA, HechtO, Carlsson MollerM, MooreGR, HederstedtL, and Le BrunNE. Crystal structure and biophysical properties of Bacillus subtilis BdbD. An oxidizing thiol:disulfide oxidoreductase containing a novel metal site. J Biol Chem, 284: 23719–23733, 2009.
17.
DenoncinK and ColletJF. Disulfide bond formation in the bacterial periplasm: major achievements and challenges ahead. Antioxid Redox Signal, 19: 63–71, 2013.
18.
DuprezW, PremkumarL, HaliliMA, LindahlF, ReidRC, FairlieDP, and MartinJL. Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence. J Med Chem, 58: 577–587, 2015.
19.
DuttonRJ, BoydD, BerkmenM, and BeckwithJ. Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation. Proc Natl Acad Sci U S A, 105: 11933–11938, 2008.
20.
EmsleyP and CowtanK. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr, 60: 2126–2132, 2004.
21.
FelsensteinJ. PHYLIP (Phylogeny Inference Package) version 3.6. Distributed by the author. Department of Genome Sciences, University of Washington, Seattle. 2005.
GrimshawJP, StirnimannCU, BrozzoMS, MalojcicG, GrutterMG, CapitaniG, and GlockshuberR. DsbL and DsbI form a specific dithiol oxidase system for periplasmic arylsulfate sulfotransferase in uropathogenic Escherichia coli. J Mol Biol, 380: 667–680, 2008.
24.
GuddatLW, BardwellJCA, GlockshuberR, HuberWunderlichM, ZanderT, and MartinJL. Structural analysis of three His32 mutants of DsbA: support for an electrostatic role of His32 in DsbA stability. Protein Sci, 6: 1893–1900, 1997.
25.
HatahetF, BoydD, and BeckwithJ. Disulfide bond formation in prokaryotes: history, diversity and design. Biochim Biophys Acta, 1844: 1402–1414, 2014.
26.
HerasB, EdelingMA, ByrielKA, JonesA, RainaS, and MartinJL. Dehydration converts DsbG crystal diffraction from low to high resolution. Structure, 11: 139–145, 2003.
27.
HerasB, KurzM, JarrottR, ShouldiceSR, FreiP, RobinG, CemazarM, Thony-MeyerL, GlockshuberR, and MartinJL. Staphylococcus aureus DsbA does not have a destabilizing disulfide. A new paradigm for bacterial oxidative folding. J Biol Chem, 283: 4261–4271, 2008.
28.
HerasB, ScanlonMJ, and MartinJL. Targeting virulence not viability in the search for future antibacterials. Br J Clin Pharmacol, 79: 208–215, 2015.
29.
HerasB, ShouldiceSR, TotsikaM, ScanlonMJ, SchembriMA, and MartinJL. DSB proteins and bacterial pathogenicity. Nat Rev Microbiol, 7: 215–225, 2009.
30.
HerasB, TotsikaM, JarrottR, ShouldiceSR, GuncarG, AchardME, WellsTJ, ArgenteMP, McEwanAG, and SchembriMA. Structural and functional characterization of three DsbA paralogues from Salmonella enterica serovar typhimurium. J Biol Chem, 285: 18423–18432, 2010.
31.
HoisethSK and StockerBA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature, 291: 238–239, 1981.
32.
HolmL, KaariainenS, RosenstromP, and SchenkelA. Searching protein structure databases with DaliLite v.3. Bioinformatics, 24: 2780–2781, 2008.
33.
HuSH, PeekJA, RattiganE, TaylorRK, and MartinJL. Structure of TcpG, the DsbA protein folding catalyst from Vibrio cholerae. J Mol Biol, 268: 137–146, 1997.
34.
InabaK, MurakamiS, SuzukiM, NakagawaA, YamashitaE, OkadaK, and ItoK. Crystal structure of the DsbB-DsbA complex reveals a mechanism of disulfide bond generation. Cell, 127: 789–801, 2006.
35.
IrelandPM, McMahonRM, MarshallLE, HaliliM, FurlongE, TayS, MartinJL, and Sarkar-TysonM. Disarming Burkholderia pseudomallei: structural and functional characterization of a disulfide oxidoreductase (DsbA) required for virulence in vivo. Antioxid Redox Signal, 20: 606–617, 2014.
36.
KimballRA, MartinL, and SaierMHJr. Reversing transmembrane electron flow: the DsbD and DsbB protein families. J Mol Microbiol Biotechnol, 5: 133–149, 2003.
37.
KpadehZZ, Jameson-LeeM, YehAJ, ChertihinO, ShumilinIA, DeyR, DaySR, and HoffmanPS. Disulfide bond oxidoreductase DsbA2 of Legionella pneumophila exhibits protein disulfide isomerase activity. J Bacteriol, 195: 1825–1833, 2013.
38.
KurthF, DuprezW, PremkumarL, SchembriMA, FairlieDP, and MartinJL. Crystal structure of the dithiol oxidase DsbA enzyme from proteus mirabilis bound non-covalently to an active site peptide ligand. J Biol Chem, 289: 19810–19822, 2014.
39.
KurthF, RimmerK, PremkumarL, MohantyB, DuprezW, HaliliMA, ShouldiceSR, HerasB, FairlieDP, ScanlonMJ, and MartinJL. Comparative sequence, structure and redox analyses of Klebsiella pneumoniae DsbA show that anti-virulence target DsbA enzymes fall into distinct classes. PLoS One, 8: e80210, 2013.
40.
KurzM, Iturbe-OrmaetxeI, JarrottR, ShouldiceSR, WoutersMA, FreiP, GlockshuberR, O'NeillSL, HerasB, and MartinJL. Structural and functional characterization of the oxidoreductase alpha-DsbA1 from Wolbachia pipientis. Antioxid Redox Signal, 11: 1485–1500, 2009.
41.
LafayeC, IwemaT, CarpentierP, Jullian-BinardC, KrollJS, ColletJF, and SerreL. Biochemical and structural study of the homologues of the thiol-disulfide oxidoreductase DsbA in Neisseria meningitidis. J Mol Biol, 392: 952–966, 2009.
42.
LasicaAM and Jagusztyn-KrynickaEK. The role of Dsb proteins of Gram-negative bacteria in the process of pathogenesis. FEMS Microbiol Rev, 31: 626–636, 2007.
43.
LemonJ.Plotrix: a package in the red light district of R. R-News, 6: 8–12, 2006.
44.
LiuYY, WangY, WalshTR, YiLX, ZhangR, SpencerJ, DoiY, TianG, DongB, HuangX, YuLF, GuD, RenH, ChenX, LvL, HeD, ZhouH, LiangZ, LiuJH, and ShenJ. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis, 16: 161–168, 2016.
45.
MajowiczSE, MustoJ, ScallanE, AnguloFJ, KirkM, O'BrienSJ, JonesTF, FazilA, HoekstraRM; International Collaboration on Enteric Disease “Burden of Illness” Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis, 50: 882–889, 2010.
46.
MartinJL, BardwellJCA, and KuriyanJ. Crystal-structure of the Dsba protein required for disulfide bond formation in-vivo. Nature, 365: 464–468, 1993.
47.
MartinJL, WaksmanG, BardwellJCA, BeckwithJ, and KuriyanJ. Crystallization of Dsba, an Escherichia-coli protein required for disulfide bond formation in vivo. J Mol Biol, 230: 1097–1100, 1993.
McGannP, SnesrudE, MaybankR, CoreyB, OngAC, CliffordR, HinkleM, WhitmanT, LeshoE, and SchaecherKE. Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: first Report of mcr-1 in the United States. Antimicrob Agents Chemother, 60: 4420–4421, 2016.
50.
McMahonRM, PremkumarL, and MartinJL. Four structural subclasses of the antivirulence drug target disulfide oxidoreductase DsbA provide a platform for design of subclass-specific inhibitors. Biochim Biophys Acta, 1844: 1391–1401, 2014.
51.
MobleyHL, GreenDM, TrifillisAL, JohnsonDE, ChippendaleGR, LockatellCV, JonesBD, and WarrenJW. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun, 58: 1281–1289, 1990.
52.
MorrisGM, HueyR, LindstromW, SannerMF, BelewRK, GoodsellDS, and OlsonAJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem, 30: 2785–2791, 2009.
53.
PaxmanJJ, BorgNA, HorneJ, ThompsonPE, ChinY, SharmaP, SimpsonJS, WielensJ, PiekS, KahlerCM, SakellarisH, PearceM, BottomleySP, RossjohnJ, and ScanlonMJ. The structure of the bacterial oxidoreductase enzyme DsbA in complex with a peptide reveals a basis for substrate specificity in the catalytic cycle of DsbA enzymes. J Biol Chem, 284: 17835–17845, 2009.
54.
PoirelL, LagruttaE, TaylorP, PhamJ, and NordmannP. Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother, 54: 4914–4916, 2010.
55.
PremkumarL, HerasB, DuprezW, WaldenP, HaliliM, KurthF, FairlieDP, and MartinJL. Rv2969c, essential for optimal growth in Mycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidases. Acta Crystallogr D Biol Crystallogr, 69: 1981–1994, 2013.
56.
PremkumarL, KurthF, DuprezW, GroftehaugeMK, KingGJ, HaliliMA, HerasB, and MartinJL. Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site. J Biol Chem, 289: 19869–19880, 2014.
57.
Reardon-RobinsonME, OsipiukJ, ChangC, WuC, JooyaN, JoachimiakA, DasA, and Ton-ThatH. A Disulfide bond-forming machine is linked to the sortase-mediated Pilus assembly pathway in the gram-positive bacterium actinomyces oris. J Biol Chem, 290: 21393–21405, 2015.
58.
Reardon-RobinsonME, OsipiukJ, JooyaN, ChangC, JoachimiakA, DasA, and Ton-ThatH. A thiol-disulfide oxidoreductase of the gram-positive pathogen corynebacterium diphtheriae is essential for viability, pilus assembly, toxin production and virulence. Mol Microbiol, 98: 1037–1050, 2015.
59.
Reardon-RobinsonME and Ton-ThatH. Disulfide-bond-forming pathways in gram-positive bacteria. J Bacteriol, 198: 746–754, 2015.
60.
RinaldiFC, MezaAN, and GuimaraesBG. Structural and biochemical characterization of Xylella fastidiosa DsbA family members: new insights into the enzyme-substrate interaction. Biochemistry, 48: 3508–3518, 2009.
61.
ShouldiceSR, HerasB, JarrottR, SharmaP, ScanlonMJ, and MartinJL. Characterization of the DsbA oxidative folding catalyst from Pseudomonas aeruginosa reveals a highly oxidizing protein that binds small molecules. Antioxid Redox Signal, 12: 921–931, 2010.
62.
ShouldiceSR, HerasB, WaldenPM, TotsikaM, SchembriMA, and MartinJL. Structure and function of DsbA, a key bacterial oxidative folding catalyst. Antioxid Redox Signal, 14: 1729–1760, 2011.
63.
SinhaS, LangfordPR, and KrollJS. Functional diversity of three different DsbA proteins from Neisseria meningitidis. Microbiology, 150: 2993–3000, 2004.
64.
SmithRP, PaxmanJJ, ScanlonMJ, and HerasB. Targeting bacterial Dsb proteins for the development of anti-virulence agents. Molecules, 21, 2016. DOI: 10.3390/molecules21070811
65.
StudierFW.Protein production by auto-induction in high density shaking cultures. Protein Expr Purif, 41: 207–234, 2005.
66.
TalyJF, MagisC, BussottiG, ChangJM, Di TommasoP, ErbI, Espinosa-CarrascoJ, KemenaC, and NotredameC. Using the T-Coffee package to build multiple sequence alignments of protein, RNA, DNA sequences and 3D structures. Nat Protoc, 6: 1669–1682, 2011.
67.
TotsikaM.Benefits and challenges of antivirulence antimicrobials at the dawn of the post-antibiotic era. Drug Deliv Lett, 6: 30–37, 2016.
68.
TotsikaM, HerasB, WurpelDJ, and SchembriMA. Characterization of two homologous disulfide bond systems involved in virulence factor biogenesis in uropathogenic Escherichia coli CFT073. J Bacteriol, 191: 3901–3908, 2009.
TrottO and OlsonAJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem, 31: 455–461, 2010.
71.
VivianJP, ScoullarJ, RimmerK, BushellSR, BeddoeT, WilceMC, ByresE, BoyleTP, DoakB, SimpsonJS, GrahamB, HerasB, KahlerCM, RossjohnJ, and ScanlonMJ. Structure and function of the oxidoreductase DsbA1 from Neisseria meningitidis. J Mol Biol, 394: 931–943, 2009.
72.
VivianJP, ScoullarJ, RobertsonAL, BottomleySP, HorneJ, ChinY, WielensJ, ThompsonPE, VelkovT, PiekS, ByresE, BeddoeT, WilceMC, KahlerCM, RossjohnJ, and ScanlonMJ. Structural and biochemical characterization of the oxidoreductase NmDsbA3 from Neisseria meningitidis. J Biol Chem, 283: 32452–32461, 2008.
73.
WallaceIM, O'SullivanO, HigginsDG, and NotredameC. M-Coffee: combining multiple sequence alignment methods with T-Coffee. Nucleic Acids Res, 34: 1692–1699, 2006.
74.
YuJ and KrollJS. DsbA: a protein-folding catalyst contributing to bacterial virulence. Microbes Infect, 1: 1221–1228, 1999.
75.
YunHJ, KwonAR, and ChoiEC. Bacterial arylsulfate sulfotransferase as a reporter system. Microbiol Immunol, 45: 673–678, 2001.
76.
ZuccaM, ScuteraS, SavoiaD. New antimicrobial frontiers. Mini Rev Med Chem, 11: 888–900, 2011.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
